Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M125Revenue $M2.0Net Margin (%)-4,494.2Altman Z-Score-6.7
Enterprise Value $M111EPS $-3.1Operating Margin %-4,392.7Piotroski F-Score1
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-4,494.2Higher ROA y-yN
Price/Book7.910-y EBITDA Growth Rate %--Quick Ratio7.2Cash flow > EarningsY
Price/Sales86.25-y EBITDA Growth Rate %--Current Ratio7.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-85.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-135.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARGS

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ARGS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ARGS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pharmstandard International S.10% Owner 2014-02-12Buy1,275,000$8-24.63 view
Underdown Brian J.Director, 10% Owner 2014-02-12Buy40,497$8-24.63 view
Cooperatieve AAC LS U.A.10% Owner 2014-02-12Buy36,416$8-24.63 view
Birner HubertDirector, 10% Owner 2014-02-12Buy39,873$8-24.63 view
van Deventer SanderDirector, 10% Owner 2014-02-12Buy36,416$8-24.63 view
Mizuho Capital No. 3 Limited P10% Owner 2014-02-06Sell0$0-24.63 view
Kyowa Hakko Kirin Co Ltd10% Owner 2014-02-06Sell0$0-24.63 view
TFG USA, LLC10% Owner 2014-02-06Sell0$0-24.63 view

Quarterly/Annual Reports about ARGS:

    News about ARGS:

    Articles On GuruFocus.com
    Investment Strategies for the Bullish Biotech Sector Jun 01 2015 
    Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

    More From Other Websites
    Argos Therapeutics Announces Formation of Scientific Advisory Board Jul 21 2015
    Argos Therapeutics Announces Formation of Scientific Advisory Board Jul 21 2015
    Argos Therapeutics to Present at 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention Jul 17 2015
    Argos Therapeutics to Present at 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention Jul 17 2015
    Argos Therapeutics Completes Enrollment in Cancer Study - Analyst Blog Jul 16 2015
    Argos Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 ADAPT Clinical... Jul 15 2015
    Argos Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 ADAPT Clinical... Jul 15 2015
    Coverage initiated on Argos Therapeutics by FBR Capital Jun 26 2015
    ARGOS THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 22 2015
    Argos Therapeutics to Present at the 2015 JMP Securities Life Sciences Conference Jun 16 2015
    Argos Therapeutics to Present at the 2015 JMP Securities Life Sciences Conference Jun 16 2015
    Argos Therapeutics Hires John D. Menditto as Vice President of Corporate Communications and Investor... Jun 15 2015
    Argos Therapeutics Hires John D. Menditto as Vice President of Corporate Communications and Investor... Jun 15 2015
    Argos Therapeutics Inc to Discuss the ADAPT Trial Update Presented at ASCO Call scheduled for 4:30... Jun 08 2015
    Independent Data Monitoring Committee Recommends Continuation of Pivotal ADAPT Phase 3 Clinical... Jun 04 2015
    Independent Data Monitoring Committee Recommends Continuation of Pivotal ADAPT Phase 3 Clinical... Jun 04 2015
    Argos Therapeutics to Present at the Annual Sachs Immuno-Oncology: BD&L and Investment Forum May 29 2015
    Argos Therapeutics to Present at the Annual Sachs Immuno-Oncology: BD&L and Investment Forum May 29 2015
    ARGOS THERAPEUTICS INC Financials May 27 2015
    Argos Therapeutics to Present at the World Stem Cells Regenerative Medicine Congress 2015 May 20 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK